Increasing Breast Cancer Screening in Chinese Immigrants

Screening Mammogram Clinical Trial

Official title:

Increasing Breast Cancer Screening in Chinese Immigrants

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05089292
• Other study ID #: STUDY-20-01174
• Secondary ID: R21CA249261
• Status: Completed
• Phase: N/A
• Start date: July 1, 2021
• Est. completion date: December 13, 2022

Study information

• Verified date: June 2024
• Source: Icahn School of Medicine at Mount Sinai
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The long-term goal of this research is to increase breast cancer screening rates in NYC Chinese immigrants. The researchers plan to accomplish this objective by developing and testing a culturally- and linguistically-adapted Witness Project program for Chinese immigrants. To inform the intervention development, the study team will identify barriers and facilitators to breast cancer screening in Chinese immigrants through individual qualitative interviews.

A total of 156 participants will be recruited during the entire study.

In Aim 1 which started in July 2021, 60 women were recruited for in-depth interviews to assess their breast cancer knowledge, perceived barriers and benefits/risks to completing mammography, perceived susceptibility to breast cancer, fatalism, screening intention, acculturation, language preference, and health literacy.

In Aim 2, 96 women will be recruited to participate in the pilot testing of the intervention. Recruitment will take place at community sites that serve Chinese immigrants in New York City. Enrollment for Aim 2 is anticipated to start in March of 2022.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 99
• Est. completion date: December 13, 2022
• Est. primary completion date: December 13, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• = 40 years of age

• female

• born in China

• read and speak Cantonese, Mandarin, or English

Exclusion Criteria:

• none

Related Conditions & MeSH terms

• Breast Neoplasms
• Screening Mammogram

Intervention

Behavioral:
• Narrative breast health education
Health education program utilizing narrative messages to promote breast cancer screening in Chinese immigrant women will be delivered in a group format in the community

Locations

Country	Name	City	State
United States	Icahn School of Medicine at Mount Sinai	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
Icahn School of Medicine at Mount Sinai	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Participants That Scored Above 80% in the Feasibility and Acceptability Questionnaire	Post-program survey to access acceptability of adapted narrative education program. Full-scale from 0% to 100%, with a higher percent indicating greater acceptability. An arbitrary cutoff value of 80% acceptance will determine the interventions' acceptability for the study.	immediately post presentation (presentation approximately 1 hour)
Primary	Number of Participants Who Were Engaged in Program	Percent of participants who showed up to the Chinese-community-based organizations and would like to participate in the program to assess engagement rate of participants	Baseline
Primary	Percentage of Community Organizations Willing to Host Program	Percentage of Chinese Community-based organizations who were willing to host the program to assess feasibility. Engagement rate of Chinese-community-based organizations was used to access feasibility	7 months
Secondary	Change in Breast Cancer Knowledge	Pre- and post-program survey to access change in breast cancer knowledge. Each correct answer counted as 1 point, each incorrect one as 0, and skipped questions as 0. Full scale from 0-6, with a higher score indicates more knowledge.	baseline and 6 months post intervention